Role of nitric oxide in lipopolysaccharide-induced mortality from spontaneously hypertensive rats

Mao Hsiung Yen, Yu Chun Liu, Hong Jye Hong, Joen Rong Sheu, Chin Chen Wu

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

To investigate whether nitric oxide (NO) contributed to a higher mortality induced by lipopolysaccharide (LPS) in spontaneously hypertensive rats (SHR), NO synthase inhibitors were used to examine the mortality from LPS in SHR and normotensive Wistar-Kyoto (WKY) rats. We evaluated the mortality from LPS in a series of doses (5, 10, or 20 mg/kg, i.v.) in the anesthetized rat. Plasma nitrite was measured before and at 1, 2, and 3 h after treated rats with LPS (5 mg/kg, i.v.). Pressure responses to N(ω)-nitro-L-arginine methyl ester (L-NAME) and aminoguanidine (AG) were performed in rats treated with or without LPS for 3 h. Thoracic aortic cyclic guanosine 3',5'-monophosphate (cGMP) levels were also assessed. Our results demonstrated that injection of LPS caused a dose-dependent mortality in both strains, having a more marked effect in SHR. The survival time of rats after injection of LPS (5 mg/kg, i.v.) was much shorter in SHR. A higher basal level of plasma nitrite was observed in SHR and this difference was further augmented by LPS. The administration of L-NAME (3 mg/kg, i.v.) and AG (15 mg/kg, i.v.) 3 h after LPS had no significant effects on the survival time of WKY rats, but significantly prolonged that of SHR to a similar time of WKY rats. The injection of L-NAME prior to LPS increased blood pressure of WKY rats by 28 ± 5 mmHg and increased that of SHR by 38 ± 4 mmHg. At 3 h after LPS, L-NAME had a greater pressor effect in SHR than in WKY rats. By contrast, before rats injected with LPS, AG slightly increased blood pressure of SHR by 7 ± 3 mmHg but not of WKY rats (3 ± 2 mmHg), whereas it also had a greater pressor effect in SHR than in WKY rats after treated rats with LPS for 3 h. In addition, LPS induced a higher level of cGMP in SHR than in WKY rats, which was attenuated by in vitro treatment of aortic rings from LPS-rats with L-NAME or AG to a similar level in SHR and WKY rats. These results suggest that a higher level of NO evoked by LPS is associated with a higher mortality in SHR and we propose that the elevated NO synthesis in SHR may play an important role in the compensatory mechanisms activated to combat the hypertensive state.

Original languageEnglish
Pages (from-to)1223-1230
Number of pages8
JournalLife Sciences
Volume60
Issue number15
DOIs
Publication statusPublished - Mar 7 1997

Fingerprint

Inbred SHR Rats
Lipopolysaccharides
Rats
Nitric Oxide
Inbred WKY Rats
Mortality
NG-Nitroarginine Methyl Ester
Cyclic GMP
Nitrites
Injections
Blood Pressure
Blood pressure
Nitric Oxide Synthase

Keywords

  • lipopolysaccharide
  • nitric oxide synthase inhibitors
  • spontaneously hypertensive rats
  • Wistar-Kyoto rats

ASJC Scopus subject areas

  • Pharmacology

Cite this

Role of nitric oxide in lipopolysaccharide-induced mortality from spontaneously hypertensive rats. / Yen, Mao Hsiung; Liu, Yu Chun; Hong, Hong Jye; Sheu, Joen Rong; Wu, Chin Chen.

In: Life Sciences, Vol. 60, No. 15, 07.03.1997, p. 1223-1230.

Research output: Contribution to journalArticle

Yen, Mao Hsiung ; Liu, Yu Chun ; Hong, Hong Jye ; Sheu, Joen Rong ; Wu, Chin Chen. / Role of nitric oxide in lipopolysaccharide-induced mortality from spontaneously hypertensive rats. In: Life Sciences. 1997 ; Vol. 60, No. 15. pp. 1223-1230.
@article{e836712d2c164c8ab1ebc8ebd36cc8ee,
title = "Role of nitric oxide in lipopolysaccharide-induced mortality from spontaneously hypertensive rats",
abstract = "To investigate whether nitric oxide (NO) contributed to a higher mortality induced by lipopolysaccharide (LPS) in spontaneously hypertensive rats (SHR), NO synthase inhibitors were used to examine the mortality from LPS in SHR and normotensive Wistar-Kyoto (WKY) rats. We evaluated the mortality from LPS in a series of doses (5, 10, or 20 mg/kg, i.v.) in the anesthetized rat. Plasma nitrite was measured before and at 1, 2, and 3 h after treated rats with LPS (5 mg/kg, i.v.). Pressure responses to N(ω)-nitro-L-arginine methyl ester (L-NAME) and aminoguanidine (AG) were performed in rats treated with or without LPS for 3 h. Thoracic aortic cyclic guanosine 3',5'-monophosphate (cGMP) levels were also assessed. Our results demonstrated that injection of LPS caused a dose-dependent mortality in both strains, having a more marked effect in SHR. The survival time of rats after injection of LPS (5 mg/kg, i.v.) was much shorter in SHR. A higher basal level of plasma nitrite was observed in SHR and this difference was further augmented by LPS. The administration of L-NAME (3 mg/kg, i.v.) and AG (15 mg/kg, i.v.) 3 h after LPS had no significant effects on the survival time of WKY rats, but significantly prolonged that of SHR to a similar time of WKY rats. The injection of L-NAME prior to LPS increased blood pressure of WKY rats by 28 ± 5 mmHg and increased that of SHR by 38 ± 4 mmHg. At 3 h after LPS, L-NAME had a greater pressor effect in SHR than in WKY rats. By contrast, before rats injected with LPS, AG slightly increased blood pressure of SHR by 7 ± 3 mmHg but not of WKY rats (3 ± 2 mmHg), whereas it also had a greater pressor effect in SHR than in WKY rats after treated rats with LPS for 3 h. In addition, LPS induced a higher level of cGMP in SHR than in WKY rats, which was attenuated by in vitro treatment of aortic rings from LPS-rats with L-NAME or AG to a similar level in SHR and WKY rats. These results suggest that a higher level of NO evoked by LPS is associated with a higher mortality in SHR and we propose that the elevated NO synthesis in SHR may play an important role in the compensatory mechanisms activated to combat the hypertensive state.",
keywords = "lipopolysaccharide, nitric oxide synthase inhibitors, spontaneously hypertensive rats, Wistar-Kyoto rats",
author = "Yen, {Mao Hsiung} and Liu, {Yu Chun} and Hong, {Hong Jye} and Sheu, {Joen Rong} and Wu, {Chin Chen}",
year = "1997",
month = "3",
day = "7",
doi = "10.1016/S0024-3205(97)00066-0",
language = "English",
volume = "60",
pages = "1223--1230",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "15",

}

TY - JOUR

T1 - Role of nitric oxide in lipopolysaccharide-induced mortality from spontaneously hypertensive rats

AU - Yen, Mao Hsiung

AU - Liu, Yu Chun

AU - Hong, Hong Jye

AU - Sheu, Joen Rong

AU - Wu, Chin Chen

PY - 1997/3/7

Y1 - 1997/3/7

N2 - To investigate whether nitric oxide (NO) contributed to a higher mortality induced by lipopolysaccharide (LPS) in spontaneously hypertensive rats (SHR), NO synthase inhibitors were used to examine the mortality from LPS in SHR and normotensive Wistar-Kyoto (WKY) rats. We evaluated the mortality from LPS in a series of doses (5, 10, or 20 mg/kg, i.v.) in the anesthetized rat. Plasma nitrite was measured before and at 1, 2, and 3 h after treated rats with LPS (5 mg/kg, i.v.). Pressure responses to N(ω)-nitro-L-arginine methyl ester (L-NAME) and aminoguanidine (AG) were performed in rats treated with or without LPS for 3 h. Thoracic aortic cyclic guanosine 3',5'-monophosphate (cGMP) levels were also assessed. Our results demonstrated that injection of LPS caused a dose-dependent mortality in both strains, having a more marked effect in SHR. The survival time of rats after injection of LPS (5 mg/kg, i.v.) was much shorter in SHR. A higher basal level of plasma nitrite was observed in SHR and this difference was further augmented by LPS. The administration of L-NAME (3 mg/kg, i.v.) and AG (15 mg/kg, i.v.) 3 h after LPS had no significant effects on the survival time of WKY rats, but significantly prolonged that of SHR to a similar time of WKY rats. The injection of L-NAME prior to LPS increased blood pressure of WKY rats by 28 ± 5 mmHg and increased that of SHR by 38 ± 4 mmHg. At 3 h after LPS, L-NAME had a greater pressor effect in SHR than in WKY rats. By contrast, before rats injected with LPS, AG slightly increased blood pressure of SHR by 7 ± 3 mmHg but not of WKY rats (3 ± 2 mmHg), whereas it also had a greater pressor effect in SHR than in WKY rats after treated rats with LPS for 3 h. In addition, LPS induced a higher level of cGMP in SHR than in WKY rats, which was attenuated by in vitro treatment of aortic rings from LPS-rats with L-NAME or AG to a similar level in SHR and WKY rats. These results suggest that a higher level of NO evoked by LPS is associated with a higher mortality in SHR and we propose that the elevated NO synthesis in SHR may play an important role in the compensatory mechanisms activated to combat the hypertensive state.

AB - To investigate whether nitric oxide (NO) contributed to a higher mortality induced by lipopolysaccharide (LPS) in spontaneously hypertensive rats (SHR), NO synthase inhibitors were used to examine the mortality from LPS in SHR and normotensive Wistar-Kyoto (WKY) rats. We evaluated the mortality from LPS in a series of doses (5, 10, or 20 mg/kg, i.v.) in the anesthetized rat. Plasma nitrite was measured before and at 1, 2, and 3 h after treated rats with LPS (5 mg/kg, i.v.). Pressure responses to N(ω)-nitro-L-arginine methyl ester (L-NAME) and aminoguanidine (AG) were performed in rats treated with or without LPS for 3 h. Thoracic aortic cyclic guanosine 3',5'-monophosphate (cGMP) levels were also assessed. Our results demonstrated that injection of LPS caused a dose-dependent mortality in both strains, having a more marked effect in SHR. The survival time of rats after injection of LPS (5 mg/kg, i.v.) was much shorter in SHR. A higher basal level of plasma nitrite was observed in SHR and this difference was further augmented by LPS. The administration of L-NAME (3 mg/kg, i.v.) and AG (15 mg/kg, i.v.) 3 h after LPS had no significant effects on the survival time of WKY rats, but significantly prolonged that of SHR to a similar time of WKY rats. The injection of L-NAME prior to LPS increased blood pressure of WKY rats by 28 ± 5 mmHg and increased that of SHR by 38 ± 4 mmHg. At 3 h after LPS, L-NAME had a greater pressor effect in SHR than in WKY rats. By contrast, before rats injected with LPS, AG slightly increased blood pressure of SHR by 7 ± 3 mmHg but not of WKY rats (3 ± 2 mmHg), whereas it also had a greater pressor effect in SHR than in WKY rats after treated rats with LPS for 3 h. In addition, LPS induced a higher level of cGMP in SHR than in WKY rats, which was attenuated by in vitro treatment of aortic rings from LPS-rats with L-NAME or AG to a similar level in SHR and WKY rats. These results suggest that a higher level of NO evoked by LPS is associated with a higher mortality in SHR and we propose that the elevated NO synthesis in SHR may play an important role in the compensatory mechanisms activated to combat the hypertensive state.

KW - lipopolysaccharide

KW - nitric oxide synthase inhibitors

KW - spontaneously hypertensive rats

KW - Wistar-Kyoto rats

UR - http://www.scopus.com/inward/record.url?scp=0030942043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030942043&partnerID=8YFLogxK

U2 - 10.1016/S0024-3205(97)00066-0

DO - 10.1016/S0024-3205(97)00066-0

M3 - Article

C2 - 9096239

AN - SCOPUS:0030942043

VL - 60

SP - 1223

EP - 1230

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 15

ER -